OR WAIT null SECS
October 21, 2010
Pfizer Forms Pact with Biocon; Baxter Makes Appointments; And More.
October 14, 2010
sanofi to Cut 25% of US Workforce; AMRI Names VP of Chemical Development; And More.
On Tuesday, Pfizer (New York) and King Pharmaceuticals (Bristol, TN), a specialty pharmaceutical-discovery and clinical-development company, entered into a definitive merger agreement under which Pfizer will acquire King for $3.6 billion in cash, or $14.25 per share.
October 07, 2010
Company and People Notes: Novartis Settles with US Attorney's Office; Hospira Names VP, And More.
October 02, 2010
The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.
The growth of biologics is an important factor for the injectable-drug delivery systems market. A look at the technical and market considerations affecting this sector.
Private companies and universities are developing new ways to deliver protein drugs.
The authors developed a formulation for effervescent gastroretentive drug delivery techniques using ibuprofen as a model drug. They optimized the formulations by applying full factorial design.
October 01, 2010
The author describes the development of small-angle X-ray scattering and analyzes its advantages in the characterization of drug-delivery systems and large molecules. This article is part of a special Analytical Technology issue.
September 30, 2010
Novartis Sells US Enablex Rights; Ricerca Names Chemistry Director; And More.